Clinical Chemistry Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 48: 799-801, 2002;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (52)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dewitte, K.
Right arrow Articles by Thienpont, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dewitte, K.
Right arrow Articles by Thienpont, L. M.
Related Collections
Right arrow Laboratory Management
Right arrow Evidence Based Laboratory Medicine and Test Utilization
(Clinical Chemistry. 2002;48:799-801.)
© 2002 American Association for Clinical Chemistry, Inc.


Letters

Application of the Bland–Altman Plot for Interpretation of Method-Comparison Studies: A Critical Investigation of Its Practice

Katy Dewitte1, Colette Fierens1, Dietmar Stöckl1 and Linda M. Thienpont1a

1 Laboratorium voor Analytische Chemie Universiteit Gent Harelbekestraat 72 9000 Gent, Belgium

aAuthor for correspondence. Fax 32-9-264-81-98; e-mail Linda.thienpont@rug.ac.be.


To the Editor:

Current guidelines for the combined graphical/statistical interpretation of method-comparison studies (1) include a scatter plot combined with correlation and regression analysis (2) and/or a difference plot combined with calculation of the 2s limits of the differences between the methods (the so-called 95% limits of agreement) (3)(4). The former approach has a long tradition in clinical chemistry, and its advantages and pitfalls are well known (5). The latter approach, however, which was deemed "simple both to do and to interpret" and was propagated as a substitute for regression analysis (4)(5), became available only in recent years and has increased in popularity. The general features of the Bland–Altman plot have been well described (4) (see also Fig. 1A ). The x axis shows the mean of the results of the two methods ([A + B]/2), whereas the y axis represents the absolute difference between the two methods ([B - A]). When the standard deviation increases with concentration, Bland and Altman recommend a logarithmic y scale, whereas others propose a percent y scale (6). Although generally there is not much difference in effect between using percentages and using a log transformation of the data, we prefer the percent plot (except when data extend over several orders of magnitude) because numbers can be read directly from the plot without the need for back-transformation. Additionally, the plot includes the line for the mean difference . . . [Full Text of this Article]


Acknowledgments


References




The following articles in journals at HighWire Press have cited this article:


Home page
J. Mol. Diagn.Home page
E. Gineikiene, M. Stoskus, and L. Griskevicius
Single Nucleotide Polymorphism-Based System Improves the Applicability of Quantitative PCR for Chimerism Monitoring
J. Mol. Diagn., January 1, 2009; 11(1): 66 - 74.
[Abstract] [Full Text] [PDF]


Home page
Med Decis MakingHome page
N. V. Dawson, M. E. Singer, L. Lenert, M. B. Patterson, S. A. Sami, I. Gonsenhouser, H. A. Lindstrom, K. A. Smyth, M. J. Barber, and P. J. Whitehouse
Health State Valuation in Mild to Moderate Cognitive Impairment: Feasibility of Computer-Based, Direct Patient Utility Assessment
Med Decis Making, April 1, 2008; 28(2): 220 - 232.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Janzen, M. Peter, S. Sander, U. Steuerwald, M. Terhardt, U. Holtkamp, and J. Sander
Newborn Screening for Congenital Adrenal Hyperplasia: Additional Steroid Profile using Liquid Chromatography-Tandem Mass Spectrometry
J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2581 - 2589.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
S. Boodhan, A. M. Maloney, and L. L. Dupuis
Extent of Agreement in Gentamicin Concentration Between Serum That Is Drawn Peripherally and From Central Venous Catheters
Pediatrics, December 1, 2006; 118(6): e1650 - e1656.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C.-C. Lin, C.-F. Chang, H.-J. Chiou, Y.-C. Sun, S.-S. Chiang, M.-W. Lin, P.-C. Lee, and W.-C. Yang
Variable Pump Flow-Based Doppler Ultrasound Method: A Novel Approach to the Measurement of Access Flow in Hemodialysis Patients
J. Am. Soc. Nephrol., January 1, 2005; 16(1): 229 - 236.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
D. Stockl, D. Rodriguez Cabaleiro, K. Van Uytfanghe, and L. M. Thienpont
Interpreting Method Comparison Studies by Use of the Bland-Altman Plot: Reflecting the Importance of Sample Size by Incorporating Confidence Limits and Predefined Error Limits in the Graphic
Clin. Chem., November 1, 2004; 50(11): 2216 - 2218.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Wang, D. H. Catlin, L. M. Demers, B. Starcevic, and R. S. Swerdloff
Measurement of Total Serum Testosterone in Adult Men: Comparison of Current Laboratory Methods Versus Liquid Chromatography-Tandem Mass Spectrometry
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 534 - 543.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. T. Olesberg, M. A. Arnold, and M. J. Flanigan
Online Measurement of Urea Concentration in Spent Dialysate during Hemodialysis
Clin. Chem., January 1, 2004; 50(1): 175 - 181.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
T. B. Ledue and N. Rifai
Preanalytic and Analytic Sources of Variations in C-reactive Protein Measurement: Implications for Cardiovascular Disease Risk Assessment
Clin. Chem., August 1, 2003; 49(8): 1258 - 1271.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
Y. Tan, X. Sun, L. Tang, N. Zhang, Q. Han, M. Xu, X. Tan, X. Tan, and R. M. Hoffman
Automated Enzymatic Assay for Homocysteine
Clin. Chem., June 1, 2003; 49(6): 1029 - 1030.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Panteghini and F. Pagani
On the Comparison of Serum and Plasma Samples in Troponin Assays
Clin. Chem., May 1, 2003; 49(5): 835 - 836.
[Full Text]


Home page
Clin. Chem.Home page
R. M. Dorizzi, M. Caputo, A. Ferrari, L. Lippa, and P. Rizzotti
Comparison of Serum and Heparin-Plasma Samples in Different Generations of Dimension Troponin I Assay
Clin. Chem., December 1, 2002; 48(12): 2294 - 2296.
[Full Text] [PDF]

eLetters:

Read all eLetters

Some additional references to comparison of methods.
Jacek Dmochowski
Clinical Chemistry Online, 26 Jun 2002 [Full text]
Another weakness of the Bland-Altman method
bruce e siskowski
Clinical Chemistry Online, 14 Jun 2005 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Association for Clinical Chemistry.